SEARCH

SEARCH BY CITATION

References

  • 1
    Hadley A, Soothill PW. Alloimmune Disorders of Pregnancy Anaemia, Thrombocytopenia and Neutropenia in the Fetus and Newborn. Cambridge, UK: Cambridge University Press, 2005. ISBN: 9780521018043.
  • 2
    NICE. Routine antenatal anti-D prophylaxis for women who are rhesus D negative. Technology appraisal guidance 156. 2008. [www.nice.org.uk/guidance/ta156]. Accessed 7 August 2014.
  • 3
    Lo YM, Hjelm NM, Fidler C, Sargent IL, Murphy MF, Chamberlain PF, et al. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N Engl J Med 1998;339:17348.
  • 4
    Finning KM, Martin PG, Soothill PW, Avent ND. Prediction of fetal D status from maternal plasma: introduction of a new noninvasive fetal RHD genotyping service. Transfusion 2002;42:107985.
  • 5
    Finning K, Martin P, Summers J, Massey E, Poole G, Daniels G. Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study. BMJ 2008;336:81618.
  • 6
    Chitty LS, Finning K, Massey E, Soothill P, Daniels G. Antenatal determination of fetal rhesus status using free fetal DNA in the maternal circulation before 20 weeks’ gestation: is routine application practical and beneficial? Arch Dis Child Fetal Neonatal Ed 2011;96(Suppl 1):Fa116.
  • 7
    Kent J, Farrell AM, Soothill P. Routine administration of Anti-D: the ethical case for offering pregnant women fetal RHD genotyping and a review of policy and practice. BMC Pregnancy Childbirth 2014;14:87.
  • 8
    Clausen FB, Christiansen M, Steffensen R, Jørgensen S, Nielsen C, Jakobsen MA, et al. Report of the first nationally implemented clinical routine screening for fetal RHD in D- pregnant women to ascertain the requirement for antenatal RhD prophylaxis. Transfusion 2012;52:7528.
  • 9
    Wikman AT, Tiblad E, Karlsson A, Olsson ML, Westgren M, Reilly M. Noninvasive single- exon fetal RHD determination in a routine screening program in early pregnancy. Obstet Gynecol 2012;120:22734.
  • 10
    de Haas M, van der Ploeg CPB, Scheffer PG, Verlinden DA, Hirschberg H, Abbink F, et al. A nation-wide fetal RHD screening programme for targeted antenatal and postnatal anti-D. ISBT Sci Ser 2012;7:1647.